undamentalytics Newsletter

Berman Richard J: insider trades

Chief executive, Director at 3 companies we cover. No open-market purchases and 22 sales not made under a pre-set plan, reported from January 8, 2010 to May 16, 2024.

What happened after Berman Richard J’s sales?

After their sales, the shares moved +7.8% against the index over 12 months on average (a negative figure means selling was the right call); 47% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Berman Richard J: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 17 −5.3% −2.3% 53% 9 −0.51 0.62 No reliable evidence
Sales, 12 months after the report 17 +7.8% +24.8% 47% 9 −0.11 0.92 No reliable evidence
Sales, 12 months after the trade 17 +9.6% +1.7% 47% 9 −0.18 0.86 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Cryoport, Inc. CYRX Chief Executive Officer014August 22, 2017May 16, 2024
Lisata Therapeutics, Inc. LSTA —05January 8, 2010December 13, 2013
Biovie Inc. BIVI —03April 6, 2023August 24, 2023

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
May 16, 2024May 15, 2024 CYRX Sale $108,688 −31.8%−63.0%−66.9%
August 24, 2023August 22, 2023 BIVI Sale $37,818 not yetnot yetnot yet
June 15, 2023May 22, 2023 BIVI Sale $67,267 −43.5%−118.0%−121.2%
May 12, 2023May 11, 2023 CYRX Sale $154,937 −43.1%−61.7%−67.2%
April 6, 2023March 27, 2023 BIVI Sale $93,584 −36.7%−120.9%−127.6%
December 5, 2022December 1, 2022 CYRX Sale $142,318 +21.7%−34.9%−35.2%
August 16, 2022August 16, 2022 CYRX Sale $116,579 −41.8%−70.8%−71.7%
September 15, 2021September 15, 2021 CYRX Sale $1,599,889 −9.5%−42.9%−39.0%
November 13, 2020November 11, 2020 CYRX Sale $1,111,000 +23.5%+25.7%+1.7%
November 21, 2019November 19, 2019 CYRX Sale $75,050 +14.4%+197.8%+189.9%
November 15, 2019November 13, 2019 CYRX Sale $151,599 +12.8%+186.2%+280.6%
March 18, 2019March 15, 2019 CYRX Sale $355,200 +53.9%+36.3%+28.0%
November 16, 2018November 14, 2018 CYRX Sale $301,782 +7.2%+37.8%+39.6%
September 7, 2018September 6, 2018 CYRX Sale $140,000 −17.2%+24.8%+22.6%
August 17, 2018August 15, 2018 CYRX Sale $256,200 −14.9%+81.9%+85.6%
May 31, 2018May 25, 2018 CYRX Sale $23,820 +2.4%+31.7%+37.2%
August 22, 2017August 14, 2017 CYRX Sale $165,389 −2.3%+83.1%+62.0%
December 13, 2013December 12, 2013 LSTA Sale $73,186 +14.3%−59.5%−56.0%
January 18, 2013December 27, 2012 LSTA Sale $88,145 not yetnot yetnot yet
September 18, 2012September 18, 2012 LSTA Sale $24,840 not yetnot yetnot yet
August 20, 2010August 18, 2010 LSTA Sale $120,000 not yetnot yetnot yet
January 8, 2010January 8, 2010 LSTA Sale $150,124 not yetnot yetnot yet

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Berman Richard J traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.